Follow
Morteza Aliashrafi
Morteza Aliashrafi
Department of Cognitive Neuroscience, Institute for Cognitive Science Studies, Tehran, Iran
Verified email at sbu.ac.ir
Title
Cited by
Cited by
Year
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
Z Molavi, S Razi, SA Mirmotalebisohi, A Adibi, M Sameni, F Karami, ...
Biomedicine & Pharmacotherapy 138, 111544, 2021
542021
Periodontal ligament stem cells as a promising therapeutic target for neural damage
F Mohebichamkhorami, R Fattahi, Z Niknam, M Aliashrafi, ...
Stem Cell Research & Therapy 13 (1), 273, 2022
192022
Association of microbiota-derived propionic acid and Alzheimer’s disease; bioinformatics analysis
M Aliashrafi, M Nasehi, MR Zarrindast, MT Joghataei, H Zali, SD Siadat
Journal of Diabetes & Metabolic Disorders 19, 783-804, 2020
92020
New Insight in Neuron Regeneration: Induction of Glia Cell to Neuron Cell
M Aliashrafi, H Zali, A Jafari
International journal of advanced biotechnology and research 7 (2), 565-72, 2016
12016
Intracerebroventricular Cutibacterium acnes Generates Manifestations of Alzheimer's Disease-like Pathology in the Rat Hippocampus
M Aliashrafi, M Nasehi, MR Zarrindast, MT Joghataei, H Zali, SD Siadat
Neuroscience 540, 103-116, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–5